Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 7Stomach Neoplasms 4Rectal Neoplasms 4Neoplasm Metastasis 2Colonic Neoplasms 2Turcot syndrome 1Recurrence 1Neoplasms 1Locally Advanced Rectal Cancer (LARC) 1Locally Advanced Colorectal Cancer 1Gastrointestinal Neoplasms 1Gastric Cancer Stage 1Adenocarcinoma of the Lower Rectum 1

Interventions

tislelizumab 1XELOX 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastric Cancer Stage × XELOX × 1 year × Clear all
NCT07068516 2025-07-16

Perioperative Tislelizumab Plus Chemotherapy Versus Chemotherapy Alone in MHC-II-Positive Gastric/GEJ Cancer

Zhejiang Cancer Hospital

Phase 3 Not yet recruiting
470 enrolled
Gastrointestinal

Gastric Cancer Stage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡